IP Library Granted Patent US 11,952,394
Granted Patent B2
US 11,952,394 · App. 17/230,278 · Granted Apr 9, 2024

Siloxane derivatives of amino acids having surface-active properties

Inventors: Edward Asirvatham (Chatham, NJ); Andrei Honciuc (Iasi, RO); Voichita Mihali (Basel, CH)
Assignee: AdvanSix Resins & Chemicals LLC
C07F7/0834
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,952,394
App. No.
17/230,278
Granted
Apr 9, 2024
Kind
B2
Abstract

The present disclosure provides siloxane derivatives of amino acids that have surface-active properties. The amino acid can be naturally-occurring or synthetic, or they may be obtained via a ring-opening reaction of a lactam, such as caprolactam. The amino acid may be functionalized with a siloxane group to form a compound that is surface-active and has surfactant characteristics. The compounds have low critical micelle concentrations (CMC) as well as the ability to lower the surface tension of a liquid.

Claims (23)

1. A method of synthesizing a siloxane derivative of an amino acid, comprising:

alkylating an amino end group of 6-aminohexanoic acid to provide a disubstituted amine; and

reacting a carboxyl end group of the disubstituted amine with 3-aminopropyltris(trimethylsiloxy)silane to provide a siloxane derivative of the amino acid.

2. A method of synthesizing a siloxane derivative of the Formula I, comprising reacting a carboxyl end group of the following N-alkylated amino acid:

with 3-aminopropyltris(trimethylsiloxy)silane to provide a siloxane derivative of the amino acid of the Formula I:

wherein R 1 and R 2 may be the same or different, and comprise at least one group selected from the group consisting of C 1 -C 6 alkyl, optionally the C 1 -C 6 alkyl may include one or more of oxygen, nitrogen, or sulfur atoms or groups that include at least one of these atoms, and the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;

n is an integer from 3 to 12;

the terminal nitrogen is optionally further substituted with R 3 , wherein R 3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C 1 -C 6 alkyl; and

an optional counterion associated with the compound which, if present, is selected from the group consisting of chloride, bromide, and iodide.

3. The method of claim 2 , wherein in Formula I, n is an integer from 3 to 6.

4. The method of claim 3 , wherein in Formula I, n is 5.

5. The method of claim 1 , further comprising the additional step, prior to said alkylating step, of ring-opening caprolactam to form the 6-aminohexanoic acid.

6. The method of claim 2 , wherein the siloxane derivative of the amino acid is 6-(dimethylamino)-N-(3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)hexanamide, having the following formula:

7. The method of claim 6 , further comprising the additional step, after said reacting step, of treating the siloxane derivative of the amino acid with hydrochloric acid to form 6-(dimethylamino)-N-(3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)hexaminium chloride, having the following formula:

8. The method of claim 6 , further comprising the additional step, after said reacting step, of treating the siloxane derivative of the amino acid with methyl iodide to form 3 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethyl silyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N,N-trimethyl-6-oxohexan-1-aminium iodide, having the following formula:

9. The method of claim 6 , further comprising the additional step, after said reacting step, of treating the siloxane derivative of the amino acid with hydrogen peroxide to form 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N-dimethyl-6-oxohexan-1-amine oxide, having the following formula:

10. The method of claim 6 , further comprising the additional step, after said reacting step, of treating the siloxane derivative of the amino acid with 1,2-butane sultone to form 4-((6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-6-oxohexyl)dimethylammonio)butane-1-sulfonate, having the following formula:

11. The method of claim 1 , wherein the siloxane derivative of the amino acid is 6-(dimethylamino)-N-(3-(1,1,1,5,5,5-hexamethyl-3-((trimethyl silyl)oxy)trisiloxan-3-yl)propyl)hexanamide, having the following formula:

12. The method of claim 1 , wherein the siloxane derivative of the amino acid is 6-(dimethylamino)-N-(3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)hexaminium chloride, having the following formula:

13. The method of claim 1 , wherein the siloxane derivative of the amino acid is 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethyl silyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N,N-trimethyl-6-oxohexan-1-aminium iodide, having the following formula:

14. The method of claim 1 , wherein the siloxane derivative of the amino acid is 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethyl silyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N-dimethyl-6-oxohexan-1-amine oxide, having the following formula:

15. The method of claim 1 , wherein the siloxane derivative of the amino acid is 4-((6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-6-oxohexyl)dimethylammonio)butane-1-sulfonate, having the following formula:

16. The method of claim 2 , further comprising the additional step, prior to said reacting step, of ring-opening caprolactam to form the 6-aminohexanoic acid.

Assignments (1)
SECURITY INTEREST Recorded Oct 27, 2021
From: ADVANSIX INC.; ADVANSIX RESINS & CHEMICALS LLC
To: TRUIST BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 057940/0794 →
Continuity (3)
Continuation 16990855 · Aug 11, 2020
Provisional Application 62890341 · Aug 22, 2019
Related Publication 20210230194A1 · Jul 29, 2021
Cited By (2)
US 12,459,963 US 12,466,846